Xinghua Han

机构：University of Science and Technology of China · ORCID：0000-0002-0632-6955

发表论文 72 篇 · 总被引 1166 次 · h-index 19

代表论文

• Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment (2025 · Molecular Cancer · 被引 65)
• LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2 (2023 · International Journal of Molecular Sciences · 被引 25)
• LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance (2024 · Oncogene · 被引 17)
• TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study (2025 · Cancer Cell · 被引 10)
• LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer (2024 · BMC Immunology · 被引 10)
• Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis (2025 · Breast Cancer Research · 被引 9)